A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain

Journal article

Open access

Peer reviewed

Sallwa M. Alshehre, Sheila Duffy, Georgina Jones, William L. Ledger and Mostafa Metwally

Reproductive biology and endocrinology, Vol.18(1), pp.28-28

14/04/2020

PMCID: PMC7155249

PMID: 32290838

Abstract

Add back therapy

Chronic cyclic pelvic pain

Endometriosis

GnRH

url

https://doi.org/10.1186/s12958-020-00586-zView

Published (Version of record) Open

1 Record Views

Title: A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain
Creators - without role: Sallwa M. Alshehre - University of Sheffield
Sheila Duffy - University of Sheffield
Georgina Jones - Leeds Beckett University
William L. Ledger - UNSW Sydney
Mostafa Metwally - University of Sheffield
Publication Details: Reproductive biology and endocrinology, Vol.18(1), pp.28-28
Publisher: BioMed Central
Identifiers: 9931795408331
Academic Unit: Umm Al Qura University
Language: English
Resource Type: Journal article